The Latest Cardiac and Vascular News
Strategic Investment Expected to Help Accelerate Cardiac Monitoring and Strategic Relationship Aims to Create Improved Disease State Treatment Models SAN JOSE, Calif.–(BUSINESS WIRE)–VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, today announced the completion of an investment funded by Health Insight Capital, the investment arm of HCA […]
Results reinforce that Amplatzer Piccolo™ Occluder is safe and effective for closing an opening in the heart known as a “patent ductus arteriosus” (PDA) in newborns Study found low adverse event rates following a Piccolo procedure, showing additional benefit of the device that can help babies avoid riskier surgery A […]
Designed to Leverage AI Technology to Improve the Delivery of Connected Care in Cardiac Diagnostics and Remote Patient Monitoring LAKE OSWEGO, Ore., Sept. 8, 2022 /PRNewswire/ — BIOTRONIK announced today its partnership with AliveCor, a leading innovator in FDA-cleared personal electrocardiogram (ECG) technology and services. This partnership will combine the strengths of BIOTRONIK’s BIOMONITOR Injectable […]
alfapump® – strong interim data / on track to report primary endpoint data of North American pivotal POSEIDON study in Q4 2022 DSR® – clinical evidence of disease-modifying heart failure drug therapy / preparations ongoing to start US phase 1b/2a MOJAVE study in H1 2023 Total liquidity position of €23.8 million and cash runway into Q3 2023 Conference call with live webcast presentation today at 03:00 pm CET / 09:00 am ET Ghent, Belgium – 8 September 2022 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” […]
SARASOTA, Fla., Sept. 8, 2022 /PRNewswire/ — PaceMate, the leading digital healthcare company in cardiac data management and remote monitoring, is pleased to announce the PaceMate Ecosystem—a strategic development of its all-in-one data platform—PaceMate™LIVE—to expand beyond cardiac remote monitoring software and service to offer full interoperability and maximized productivity for device clinics, […]
SHANGHAI, Sept. 8, 2022 /PRNewswire/ — Pulnovo Medical Limited, a globally recognized OTM innovative platform, today announced that it has successfully concluded the first Steering Committee meeting for PADN Global Clinical Trial. As members of the Steering Committee, the world’s leading cardiopulmonary experts presented and discussed about the future clinical workflow and the latest […]
A global leader in the endovascular space will collaborate with the Company as it goes through the regulatory process and future commercialization HINGHAM, Mass., Sept. 08, 2022 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), which continues to build a reputation within the interventional radiology community for its LIBERTY® Robotic System, […]
This is the second Fast Track designation issued by the FDA for abelacimab Abelacimab is a dual-acting, once-monthly, fully human monoclonal antibody targeting both Factor XI and Factor XIa with high affinity and selectivity CAMBRIDGE, Mass., Sept. 08, 2022 (GLOBE NEWSWIRE) — Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for […]
The partnership will bring medically supported virtual cardiac rehabilitation and recovery into the homes of patients in Tampa General’s 23-county service area NEW YORK & TAMPA, Fla., Sept. 08, 2022 (GLOBE NEWSWIRE) — Recora today announced that it is partnering with the Tampa General Hospital Heart & Vascular Institute for its Cardiac Recovery Program. […]
HANOVER, Germany–(BUSINESS WIRE)–Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced the CE marking of its PCR kit which measures circulating microRNA-132 (miR-132) levels in the blood of patients receiving the company’s lead candidate CDR132L, an oligonucleotide-based miR-132 inhibitor. The company […]
